Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 1 of 13

Healthcare staff and leaders gather in a hospital corridor as two men cut a red ribbon during the opening of a new bronchoscopy suite.
October 26, 2026

State-of-the-art Bronchoscopy Laboratory will transform pulmonary care for Vanderbilt Health patients

Bronchoscopy is a procedure that allows medical teams to view, treat and biopsy tissue inside the lungs using a thin, flexible tube called a bronchoscope. The new space will double capacity to allow 5,000 bronchoscopies a year.

(CDC Public Image Library)
October 8, 2026

Research study aims to clarify alpha-gal syndrome diagnosis and treatment

Alpha-gal syndrome is an allergic condition associated with tick bites that can trigger severe reactions to a sugar molecule called galactose-alpha-1,3-galactose, or alpha-gal, found in red meat.

Conceptual biotechnology scene showing gloved laboratory workers, test tubes, a pipette, and overlaid medical graphics including DNA-like molecular structures, human anatomy icons, a heartbeat waveform, charts, and a digital human figure.
September 2, 2026

Millions get wrong genetic test, study finds

A study shows current testing is providing false reassurance about genetic disposition for a rare life-threatening drug reaction.

(courtesy of the CDC)
July 15, 2026

Vanderbilt Health physicians treating more patients with tick bites this year

Six medically important tick species live in the state, and many Tennesseans encounter ticks in their own yard or neighborhood. Perhaps attributable to changing weather patterns and rising temperatures, Vanderbilt Health’s Emergency Medicine physicians around the region began treating patients with tick bites in March this year.

Laurel Eiler, identified in the caption, smiles and extends her hand toward a guest while holding a small plate at a World Bronchiectasis Day gathering; other attendees stand nearby.
July 9, 2026

Bronchiectasis Day gathering at Langford Auditorium

The Vanderbilt Health NTM and Bronchiectasis Center, a program of the Vanderbilt Lung Institute, launched in 2023. The chronic lung disease is estimated to affect 350,000 to 500,000 adults in the United States.

(iStock)
June 1, 2026

Vanderbilt Health study explores GLP-1 therapies to improve asthma outcomes in patients with obesity  

The study is still recruiting participants. It will conclude in 2026 and provide insight for further investigations into the role GLP-1 agonists may offer in treating respiratory illnesses and overall immune responses.